Ultrasound‐Guided Percutaneous Sclerotherapy With Bleomycin for Management of Infantile Subcutaneous Hemangioma: A Case Report
Open Access
- 11 February 2025
- journal article
- Published by Wiley in Clinical Case Reports
- Vol. 13 (2) , e70143
Abstract
Percutaneous sclerotherapy with bleomycin is an effective, minimally invasive treatment for aggressive pediatric hemangiomas, especially when traditional therapies fail. This approach can improve clinical outcomes, including thrombocytopenia resolution and tumor size reduction, with minimal systemic side effects.Keywords
This publication has 27 references indexed in Scilit:
- Whole-lesion assessment of volume and signal changes after sclerotherapy of extremity venous malformationsEuropean Journal of Radiology, 2024
- A New Radiological Scoring System as a Method of Assessing Sclerotherapy Treatment Response for Aneurysmal Bone Cysts: A Retrospective StudyIndian Journal of Radiology and Imaging, 2024
- Percutaneous ethanolamine oleate sclerotherapy for aggressive vertebral hemangioma: A case reportRadiology Case Reports, 2023
- Bleomycin-triamcinolone sclerotherapy in the management of propranolol resistant infantile hemangioma of the maxillofacial region: A single arm prospective evaluation of clinical outcome and Doppler ultrasound parametersJournal of Stomatology Oral and Maxillofacial Surgery, 2022
- Infantile HemangiomasDermatologic Clinics, 2022
- Radiologically guided percutaneous aspiration and sclerotherapy of symptomatic simple renal cysts: a systematic review of outcomesAbdominal Radiology, 2021
- Systematic review on percutaneous aspiration and sclerotherapy versus surgery in symptomatic simple hepatic cystsHPB, 2021
- Lymphatic malformations in children: treatment outcomes of sclerotherapy in a large cohortEuropean Journal of Pediatrics, 2020
- Sirolimus and mTOR Inhibitors: A Review of Side Effects and Specific Management in Solid Organ TransplantationDrug Safety, 2019
- Kaposiform hemangioendothelioma in children: a benign vascular tumor with multiple treatment optionsWorld Journal of Pediatrics, 2018